{
    "SPADE_UN_13809": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13809",
            "Peptide Name": "17BIPHE2",
            "Source": "Synthetic construct(derived from LL-37)",
            "Family": "Filoviridae",
            "Gene": "Not found",
            "Sequence": "GXKRLVQRLKDXLRNLV",
            "Sequence Length": 17,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.32252021]Ebola Virus(EBOV):inhibition of viral infection in Hela cells(IC50=0.71 µM);inhibition of viral infection in primary macrophages(IC50=5.6 µM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "Mixed(D-Leu5, 9, 13)",
            "Structure Description": "Not found",
            "Formula": "C61H103N25O12",
            "Mass": 2030.86,
            "PI": 11.72,
            "Net Charge": 4,
            "Hydrophobicity": -1.177,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "Act as CatB inhibitors to block the endosomal processing of EBOV GP, thus preventing virus entry.",
            "Literature": [
                {
                    "Title": "Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.",
                    "Pubmed ID": "32252021",
                    "Reference": "iScience. 2020 Apr 24;23(4)100999.",
                    "Author": "Yu Y, Cooper CL, Wang G, Morwitzer MJ, Kota K, Tran JP, Bradfute SB, Liu Y, Shao J, Zhang AK, Luo LG, Reid SP, Hinrichs SH, Su K.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32252021"
                },
                {
                    "Title": "Amino Acid Composition Determines Peptide Activity Spectrum and Hot-Spot-Based Design of Merecidin",
                    "Pubmed ID": "",
                    "Author": "Wang X, Mishra B, Lushnikova T, narayana JL, Wang G"
                },
                {
                    "Title": "Arginine-lysine positional swap of the LL-37 peptides reveals evolutional advantages of the native sequence and leads to bacterial probes",
                    "Pubmed ID": "",
                    "Author": "Wang X, Junior JCB, Mishra B, Lushnikova T, Epand RM, Wang G"
                }
            ],
            "Frequent Amino Acids": "LRK",
            "Absent Amino Acids": "ACEFHIMOPSTUWY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 6,
            "Polar Residues": 9,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00227",
                    "Similarity": 1.0,
                    "Sequence": "QGIGVGDNDGKRGKR"
                },
                {
                    "SPADE_ID": "SPADE_N_13068",
                    "Similarity": 1.0,
                    "Sequence": "GKRLVQLKDLRNLV"
                },
                {
                    "SPADE_ID": "SPADE_UN_12423",
                    "Similarity": 1.0,
                    "Sequence": "GKRLVQRLKDFLRNLV"
                }
            ]
        }
    }
}